• Corvex entered an at-the-market sales agreement with Chardan Capital Markets on October 14, 2026, to sell common stock from time to time.
• Chardan will receive a commission of 2.5% of aggregate gross proceeds.
• Net proceeds are intended for working capital and general corporate purposes.
• The company has no obligation to sell shares and may suspend the offering at any time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corvex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-109462), on October 14, 2026, and is solely responsible for the information contained therein.